The James Esparza Law Firm
Product Liability Lawyers
Salt Lake City, Utah
Crestor
Please Note: The pharmaceutical liability attorneys at the James Esparaza law firm have represented countless clients in the Utah area who have been harmed by dangerous drugs, and we can help you, too. However, at this time, we are only accepting pharmaceutical liability cases for the following drugs: Levaquin, Yaz and Yasmin, and Transvaginal Mesh Patches. The link here indicates the drug cases we are no longer accepting so that we may focus our time and resources on victims who have been harmed by Levaquin, Yaz/Yasmin and the Transvaginal patches.
Crestor is one of the latest drugs to hit the market in the quest to lower high cholesterol. The U.S. Food and Drug Administration (FDA) approved Crestor in August 2003 as the newest in the "statin" family of cholesterol-lowering drugs. Almost immediately, those patients whose physicians prescribed Crestor were submitting potentially harmful side effect claims.
These claims included concerns about a potentially deadly condition known as rhabdomyolysis. Rhabdomyolysis is a muscle-damaging side effect of statins, including Crestor, which results in muscle cell breakdown and release of the contents of muscle cells into the bloodstream. Symptoms of rhabdomyolysis include:
- Muscle pain
- Weakness
- Tenderness
- Malaise
- Fever
- Dark urine
- Nausea and vomiting
In studies conducted before the drug's approval, several people were injured by cases of rhabdomyolysis.
The consumer advocacy group, Public Citizen, requested that the FDA ban the marketing of Crestor in March 2004. They cited three cases of kidney failure and death among patients taking the recommended dosages of Crestor. An additional seven cases of rhabdomyolysis and nine cases of kidney damage or failure have been reported throughout Canada and the United Kingdom.
